title: [Desmopressin: the treatment of primary nocturnal enuresis].
abstract: OBJECTIVE
  The efficacy of desmopressin, a drug that reduces nocturnal urine volume with no side effects, was evaluated in a group of 21 patients.
  
  
  METHODS
  20 boys and 1 girl with primary nocturnal enuresis were treated with intranasal desmopressin (DDAVP) for a period of 12 weeks.
  
  
  RESULTS
  An improvement in 80.95% was achieved. Following treatment enuresis recurred, but to a lesser degree than before therapy.
  
  
  CONCLUSIONS
  DDAVP is useful in the treatment of primary nocturnal enuresis whose etiology is not organic or functional.
authors.affiliation: Unidad de Urología Pediátrica, Fundación Puigvert, Barcelona, España.
authors.forename: E A
authors.initials: EA
authors.lastname: Granados
authors.forename: J M
authors.initials: JM
authors.lastname: Garat
mesh_terms: D000293:Adolescent; D002648:Child; D002908:Chronic Disease; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage* / Q000009:adverse effects; D004341:Drug Evaluation; D004775:Enuresis / Q000188:drug therapy* / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D012008:Recurrence; D013997:Time Factors
chemical_list: D003894:Deamino Arginine Vasopressin
vernacular_title: Desmopresina: el tratamiento en la enuresis nocturna primaria.